Literature DB >> 10785786

Right Radial Access for PTCA: A Prospective Study Demonstrates Reduced Complications and Hospital Charges.

.   

Abstract

OBJECTIVE: The purpose of the present study was to evaluate the hypothesis that angioplasty from the radial artery approach is more cost effective than that from the femoral artery approach.
BACKGROUND: Previous studies have demonstrated that angioplasty can safely and effectively be performed from the radial artery approach with a virtual absence of access-site complications.
METHODS: One-hundred fifty-two patients were prospectively randomized to have their angioplasty performed from either the radial or femoral approach. Angioplasty results as well as various cost factors were compared.
RESULTS: Primary success, number of stents deployed, emergency bypass surgery, PTCA time, fluoroscopy time, amount of contrast media, and catheterization laboratory charge were not significantly different in the two groups. Access-site complications (0 RRA vs. 4 RFA, p <.04), post-procedure length of stay (2.1 days +/- 0.1 RRA vs. 2.6 +/- 0.3 RFA, p <.04), total hospital length of stay (3.6 days +/- 0.2 RRA vs. 4.5 +/- 0.4 RFA, p <.03), and total hospital charge ($14,374 +/- 467 RRA vs. 15,796 +/- 702, p <.05) were all significantly less in the radial group.
CONCLUSION: PTCA can be performed from RRA as effectively as RFA without clinically significant access-site complications. Both post-procedure and total hospital stay are reduced, leading to a 9% reduction in total hospital charges.

Entities:  

Year:  1996        PMID: 10785786

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  21 in total

Review 1.  Radial artery access for coronary angiography and percutaneous coronary intervention.

Authors:  R Andrew Archbold; Nicholas M Robinson; Richard J Schilling
Journal:  BMJ       Date:  2004-08-21

2.  Critical hand ischaemia after transradial cardiac catheterisation: an uncommon complication of a common procedure.

Authors:  L M Rademakers; G J Laarman
Journal:  Neth Heart J       Date:  2012-09       Impact factor: 2.380

Review 3.  Radial versus femoral access for percutaneous coronary intervention: implications for vascular complications and bleeding.

Authors:  Sandeep Nathan; Sunil V Rao
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

4.  Transradial access in percutaneous coronary interventions: technique and procedure.

Authors:  J B Dahm; H G Wolpers; J Becker; C Hansen; S B Felix
Journal:  Herz       Date:  2010-10       Impact factor: 1.443

Review 5.  Arterial prehabilitation: can exercise induce changes in artery size and function that decrease complications of catheterization?

Authors:  Amr Alkarmi; Dick H J Thijssen; Khalled Albouaini; N Timothy Cable; D Jay Wright; Daniel J Green; Ellen A Dawson
Journal:  Sports Med       Date:  2010-06-01       Impact factor: 11.136

Review 6.  Transcarpal cardiac catheterization.

Authors:  Torsten Schwalm
Journal:  Dtsch Arztebl Int       Date:  2009-10-16       Impact factor: 5.594

7.  Comparative study of the radial and femoral artery approaches for diagnostic coronary angiography.

Authors:  Mansour Sallam; Hafidh Al-Hadi; S Rathinasekar; Sunil Chandy
Journal:  Sultan Qaboos Univ Med J       Date:  2009-12-19

Review 8.  The transradial approach. An increasingly used standard for coronary diagnosis and interventions.

Authors:  J Ludwig; S Achenbach; W G Daniel; M Arnold
Journal:  Herz       Date:  2011-08       Impact factor: 1.443

9.  Ultrasound guided percutaneous thrombin injection in a radial artery pseudoaneurysm following percutaneous coronary intervention.

Authors:  Pascal Bauer; Ahmed Koshty; Christian W Hamm; Dursun Gündüz
Journal:  Clin Res Cardiol       Date:  2014-07-22       Impact factor: 5.460

10.  Radial access for cerebrovascular procedures: Case report and technical note.

Authors:  Sudhakar R Satti; Ansar Z Vance; Thinesh Sivapatham
Journal:  Interv Neuroradiol       Date:  2015-12-11       Impact factor: 1.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.